(Q46344082)

21 December 2017

review article

1 reference

title

The role of advanced glycation end-products (AGEs) in the development of vascular diabetic complications (English)

1 reference

21 December 2017

author name string

Júnia H P Barbosa

series ordinal

1

1 reference

21 December 2017

Suzana L Oliveira

series ordinal

2

1 reference

21 December 2017

Luci Tojal e Seara

series ordinal

3

1 reference

21 December 2017

language of work or name

Portuguese

0 references

publication date

1 August 2008

1 reference

21 December 2017

Arquivos Brasileiros de Endocrinologia e Metabologia

published in

1 reference

21 December 2017

volume

52

1 reference

21 December 2017

issue

6

1 reference

21 December 2017

page(s)

940-950

1 reference

21 December 2017

Biochemistry and molecular cell biology of diabetic complications

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Advanced glycation endproducts--role in pathology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Diabetes and advanced glycoxidation end products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

The role of dicarbonyl compounds in non-enzymatic crosslinking: a structure-activity study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Oxidative stress and diabetic cardiovascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Glyco-oxidation in diabetes and related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Serum levels of low molecular weight advanced glycation end products in diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

The discovery of glycated hemoglobin: a major event in the study of nonenzymatic chemistry in biological systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

The pathobiology of diabetic complications: a unifying mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Level of an advanced glycated end product is genetically determined: a study of normal twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Advanced glycation in health and disease: role of the modern environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Advanced glycoxidation end products in commonly consumed foods

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Diabetes and advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Tobacco smoke is a source of toxic reactive glycation products

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

The enzymatic defence against glycation in health, disease and therapeutics: a symposium to examine the concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Immunohistochemical detection of an AGE, a ligand for macrophage receptor, in peritoneum of CAPD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

TAGE (toxic AGEs) hypothesis in various chronic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Advanced glycation end products: sparking the development of diabetic vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Roles of the receptor for advanced glycation endproducts in diabetes-induced vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Diabetic retinopathy: seeing beyond glucose-induced microvascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Pathogenesis and intervention strategies in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Increased levels of advanced glycation end products in human cataractous lenses

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

21 January 2018

Cutaneous wound healing

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Glycation products as markers and predictors of the progression of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complicat

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Simple noninvasive measurement of skin autofluorescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Accumulation of advanced glycation end products, measured as skin autofluorescence, in renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Noninvasive type 2 diabetes screening: superior sensitivity to fasting plasma glucose and A1C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Novel therapeutic strategies for reducing arterial stiffness

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Insulin resistance and type 2 diabetes in high-fat-fed mice are linked to high glycotoxin intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Fetal or neonatal low-glycotoxin environment prevents autoimmune diabetes in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Inhibitors of the Maillard reaction and AGE breakers as therapeutics for multiple diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Green tea impedes dyslipidemia, lipid peroxidation, protein glycation and ameliorates Ca2+ -ATPase and Na+/K+ -ATPase activity in the heart of streptozotocin-diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Ilex paraguariensis extracts inhibit AGE formation more efficiently than green tea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Effect of an aqueous extract of Phaseolus vulgaris on the properties of tail tendon collagen of rats with streptozotocin-induced diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Paradoxical effects of green tea (Camellia sinensis) and antioxidant vitamins in diabetic rats: improved retinopathy and renal mitochondrial defects but deterioration of collagen matrix glycoxidation and cross-linking

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

The low-AGE content of low-fat vegan diets could benefit diabetics - though concurrent taurine supplementation may be needed to minimize endogenous AGE production

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Anti-crosslinking properties of carnosine: significance of histidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

Glucose, Advanced Glycation End Products, and Diabetes Complications: What Is New and What Works

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000600005

10.1590/S0004-27302008000600005

21 January 2018

Identifiers

DOI

1 reference

21 December 2017

PubMed ID

18820805

1 reference

21 December 2017